Rebecca Gelman

27.4k total citations · 3 hit papers
223 papers, 16.1k citations indexed

About

Rebecca Gelman is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Rebecca Gelman has authored 223 papers receiving a total of 16.1k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Cancer Research, 92 papers in Oncology and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Rebecca Gelman's work include Breast Cancer Treatment Studies (85 papers), Cancer Treatment and Pharmacology (51 papers) and Breast Lesions and Carcinomas (33 papers). Rebecca Gelman is often cited by papers focused on Breast Cancer Treatment Studies (85 papers), Cancer Treatment and Pharmacology (51 papers) and Breast Lesions and Carcinomas (33 papers). Rebecca Gelman collaborates with scholars based in United States, South Africa and Israel. Rebecca Gelman's co-authors include Jay R. Harris, Stuart J. Schnitt, Abram Recht, James L. Connolly, Barbara Silver, I. Craig Henderson, Eric P. Winer, Fred H. Hochberg, Mark T. Jennings and Harold J. Burstein and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Rebecca Gelman

219 papers receiving 15.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intracranial germ-cell tumors: natural history and pathogenesis

1985 582 citations Rebecca Gelman et al. profile →
Lymphocyte subsets in healthy children from birth through 18 years of age

2003 560 citations Rebecca Gelman et al. profile →
Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

2003 554 citations Johanna C. Bendell, Susan M. Domchek et al. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebecca Gelman United States	63	6.8k	6.5k	3.6k	2.6k	2.4k	223	16.1k
Terry L. Smith United States	65	7.7k 1.1×	4.2k 0.6×	2.9k 0.8×	2.6k 1.0×	2.8k 1.2×	154	16.0k
Pinuccia Valagussa Italy	68	11.8k 1.7×	8.6k 1.3×	6.5k 1.8×	3.6k 1.4×	1.8k 0.7×	256	19.0k
Franco Rilke Italy	53	5.5k 0.8×	5.1k 0.8×	4.4k 1.2×	1.6k 0.6×	2.2k 0.9×	198	12.3k
Gianni Bonadonna Italy	75	11.3k 1.7×	5.9k 0.9×	7.5k 2.1×	3.9k 1.5×	2.1k 0.9×	373	20.2k
M. Elizabeth Hammond United States	28	6.7k 1.0×	4.0k 0.6×	1.7k 0.5×	2.0k 0.8×	2.2k 0.9×	60	11.5k
Joseph A. Sparano United States	64	10.4k 1.5×	5.3k 0.8×	2.3k 0.6×	2.7k 1.0×	3.7k 1.5×	397	15.9k
Justin Stebbing United Kingdom	67	6.1k 0.9×	3.5k 0.5×	1.9k 0.5×	2.1k 0.8×	4.3k 1.8×	524	14.8k
J. Milburn Jessup United States	53	11.9k 1.8×	4.0k 0.6×	3.7k 1.0×	5.4k 2.1×	6.2k 2.6×	144	20.7k
Philip J. Johnson United Kingdom	77	5.9k 0.9×	3.6k 0.5×	2.4k 0.7×	2.9k 1.1×	3.5k 1.4×	318	21.8k
Richard Greil Austria	67	10.9k 1.6×	3.9k 0.6×	4.2k 1.1×	4.1k 1.6×	5.3k 2.2×	731	20.1k

Countries citing papers authored by Rebecca Gelman

Since Specialization

Citations

This map shows the geographic impact of Rebecca Gelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebecca Gelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebecca Gelman more than expected).

Fields of papers citing papers by Rebecca Gelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebecca Gelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebecca Gelman. The network helps show where Rebecca Gelman may publish in the future.

Co-authorship network of co-authors of Rebecca Gelman

This figure shows the co-authorship network connecting the top 25 collaborators of Rebecca Gelman. A scholar is included among the top collaborators of Rebecca Gelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebecca Gelman. Rebecca Gelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ojikutu, Bisola O., Emanuele Mazzola, Andrew Fullem, et al.. (2016). HIV Testing Among Black and Hispanic Immigrants in the United States. AIDS Patient Care and STDs. 30(7). 307–314. 17 indexed citations

Nakhlis, Faina, Lauren Gilmore, Rebecca Gelman, et al.. (2015). Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020). Annals of Surgical Oncology. 23(3). 722–728. 59 indexed citations

Lin, Nancy U., Davinia Seah, Rebecca Gelman, et al.. (2013). A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer. Breast Cancer Research and Treatment. 139(2). 403–410. 15 indexed citations

Golshan, Mehra, Judy E. Garber, Rebecca Gelman, et al.. (2010). Does Neoadjuvant Bevacizumab Increase Surgical Complications in Breast Surgery?. Annals of Surgical Oncology. 18(3). 733–737. 26 indexed citations

Park, So Yeon, Hee Eun Lee, Hailun Li, et al.. (2010). Heterogeneity for Stem Cell–Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer. Clinical Cancer Research. 16(3). 876–887. 325 indexed citations

Miron, Alexander, Mária Váradi, Daniel R. Carrasco, et al.. (2010). PIK3CA Mutations in In situ and Invasive Breast Carcinomas. Cancer Research. 70(14). 5674–5678. 107 indexed citations

Kleer, Celina G., Noga Bloushtain-Qimron, Yu‐Hui Chen, et al.. (2008). Epithelial and Stromal Cathepsin K and CXCL14 Expression in Breast Tumor Progression. Clinical Cancer Research. 14(17). 5357–5367. 80 indexed citations

Permar, Sallie R., Helen H. Kang, Angela Carville, et al.. (2008). Potent Simian Immunodeficiency Virus-Specific Cellular Immune Responses in the Breast Milk of Simian Immunodeficiency Virus-Infected, Lactating Rhesus Monkeys. The Journal of Immunology. 181(5). 3643–3650. 20 indexed citations

Burstein, Harold J., Aparna Keshaviah, Ari David Baron, et al.. (2007). Trastuzumab plus vinorelbine or taxane chemotherapy for HER2‐overexpressing metastatic breast cancer: The trastuzumab and vinorelbine or taxane study. Cancer. 110(5). 965–972. 152 indexed citations

10.

Harris, Lyndsay N., Fanglei You, Stuart J. Schnitt, et al.. (2007). Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer. Clinical Cancer Research. 13(4). 1198–1207. 190 indexed citations

11.

Yao, Jun, Stanislawa Weremowicz, Bin Feng, et al.. (2006). Combined cDNA Array Comparative Genomic Hybridization and Serial Analysis of Gene Expression Analysis of Breast Tumor Progression. Cancer Research. 66(8). 4065–4078. 133 indexed citations

12.

Vogler, Mary, Hedy Teppler, Rebecca Gelman, et al.. (2004). Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248). JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(1). 576–587. 15 indexed citations

13.

Burstein, Harold J., Lyndsay N. Harris, P. Kelly Marcom, et al.. (2003). Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm. Journal of Clinical Oncology. 21(15). 2889–2895. 255 indexed citations

14.

Bendell, Johanna C., Susan M. Domchek, Harold J. Burstein, et al.. (2003). Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma. Cancer. 97(12). 2972–2977. 554 indexed citations breakdown →

15.

Sha, Beverly E., Hernán Valdez, Rebecca Gelman, et al.. (2002). Short Communication : Effect of Etanercept (Enbrel) on Interleukin 6, Tumor Necrosis Factor α , and Markers of Immune Activation in HIV-Infected Subjects Receiving Interleukin 2. AIDS Research and Human Retroviruses. 18(9). 661–665. 39 indexed citations

16.

Burstein, Harold J., Lyndsay N. Harris, Rebecca Gelman, et al.. (2002). Preoperative Therapy With Trastuzumab and Paclitaxel Followed by Sequential Adjuvant Doxorubicin/Cyclophosphamide for HER2 Overexpressing Stage II or III Breast Cancer: A Pilot Study. Journal of Clinical Oncology. 21(1). 46–53. 221 indexed citations

17.

Signoretti, Sabina, Francesca Monti, Beth Isaac, et al.. (2001). The p27 ubiquitin ligase skp2 is overexpressed in breast cancer. Open Repository and Bibliography (University of Liège). 1 indexed citations

18.

Chang, A. Y., Mary Putt, Kishan J. Pandya, et al.. (1998). Induction Chemotherapy of Dibromodulcitol, Adriamycin®, Vincristine, Tamoxifen, and Halotestin® with Methotrexate in Metastatic Breast Cancer. American Journal of Clinical Oncology. 21(1). 99–104. 1 indexed citations

19.

Yamauchi, Hideko, et al.. (1997). Prediction of response to antiestrogen therapy in advanced breast cancer patients by pretreatment circulating levels of extracellular domain of the HER-2/c-neu protein.. Journal of Clinical Oncology. 15(7). 2518–2525. 187 indexed citations

20.

Rose, Mary Ann, I. Craig Henderson, Rebecca Gelman, et al.. (1989). Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. International Journal of Radiation Oncology*Biology*Physics. 17(4). 711–717. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact